Bertolini F, Battaglia M, Soligo D, Corsini C, Curioni C, Lazzari L, Pedrazzoli P, Thalmeier K
Division of Medical Oncology, IRCCS Maugeri Foundation, Pavia, Italy.
Exp Hematol. 1997 Apr;25(4):350-6.
Berardi et al. (Science 1995; 267:105) reported recently that combined cytokine stimulation and antimetabolite treatment were able to isolate cells with characteristics of hemopoietic stem cells. Bone marrow (BM) low-density cells were cultured for 1 week in the presence of Steel factor (SF), IL-3, and the antimetabolite 5-FU. Following this approach one in 10(5) BM cells were purified. These cells showed no clonogenic potential in soft gel assays but presented a striking myeloid-lymphoid potential as long-term culture-initiating cells (LTC-ICs). We investigated this new "stem cell candidate." following a similar approach we purified one in 55,000/130,000 cells from cord blood and peripheral blood in mobilized cancer patients. These cells displayed no clonogenic potential in methylcellulose assays in the presence of different cytokine combinations and generated very few or no clonogenic progenitors in liquid cultures in the presence of cytokines. When seeded on layers derived from the murine BM stromal cell line M2-10B4, 38-86% of the cells purified using this approach generated multilineage progenitors acting as LTC-lCs. In a different series of studies, after 5-week culture on human BM stromal cell line L87/4 layers, cells were forced to selected lineage differentiation by culture in the presence of low concentrations of SF and high concentrations of lineage-specific cytokines such as Flt3-ligand (myeloid and pre-B cell differentiation), Tpo (megakaryocytic differentiation). IL-7, and IL-2 (pre-B and NK differentiation). After 12-day culture under these conditions, generation of myeloid, pre-B, megakaryocytic, and NK progenitors was assessed by immunohistochemistry, flow cytometry, and mRNA expression of CD7, 14, 19, 41b, S6, and 61. We conclude that this procedure for multilineage progenitor cell purification is simple and effective and could have major implications for gene transfer and stem cell transplantation.
贝拉尔迪等人(《科学》,1995年;267卷:105页)最近报道,细胞因子联合刺激和抗代谢物治疗能够分离出具有造血干细胞特征的细胞。骨髓(BM)低密度细胞在干细胞因子(SF)、白细胞介素-3(IL-3)和抗代谢物5-氟尿嘧啶(5-FU)存在的情况下培养1周。采用这种方法,每10⁵个BM细胞中有1个被纯化。这些细胞在软琼脂分析中没有克隆形成潜力,但作为长期培养起始细胞(LTC-ICs)表现出显著的髓系-淋巴系潜力。我们研究了这种新的“干细胞候选物”。采用类似方法,我们从动员的癌症患者的脐带血和外周血中每55000/130000个细胞中纯化出1个细胞。在不同细胞因子组合存在的情况下,这些细胞在甲基纤维素分析中没有克隆形成潜力,并且在细胞因子存在的液体培养中产生的克隆形成祖细胞很少或没有。当接种到源自小鼠BM基质细胞系M2-10B4的层上时,使用这种方法纯化的细胞中有38%-86%产生了作为LTC-ICs的多谱系祖细胞。在另一系列研究中,在人BM基质细胞系L87/4层上培养5周后,通过在低浓度SF和高浓度谱系特异性细胞因子如Flt3配体(髓系和前B细胞分化)、血小板生成素(Tpo,巨核细胞分化)、IL-7和IL-2(前B和NK分化)存在的情况下培养,迫使细胞进行选定谱系的分化。在这些条件下培养12天后,通过免疫组织化学、流式细胞术以及CD7、14、19、41b、S6和61的mRNA表达评估髓系、前B、巨核细胞和NK祖细胞的生成。我们得出结论,这种多谱系祖细胞纯化程序简单有效,可能对基因转移和干细胞移植具有重要意义。